- Home
- GXAI vs PMI Comparison
GXAI vs PMI Comparison
Compare GXAI & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | GXAI | PMI |
|---|---|---|
| Founded | 2021 | 1981 |
| Country | United States | United States |
| Employees | N/A | 75 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3M | 14.1M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | GXAI | PMI |
|---|---|---|
| Price | $1.18 | $0.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.3M | ★ 30.1M |
| Earning Date | 05-14-2026 | 06-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.35 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,933,030.00 | N/A |
| Revenue This Year | $271.23 | N/A |
| Revenue Next Year | $36.32 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 47901.74 | N/A |
| 52 Week Low | $1.02 | $0.11 |
| 52 Week High | $2.96 | $13.68 |
Technical Indicators
Market Signals| Indicator | GXAI | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 44.72 | 36.17 |
| Support Level | $1.06 | $0.15 |
| Resistance Level | $1.32 | $0.27 |
| Average True Range (ATR) | 0.07 | 0.04 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 29.06 | 1.94 |
Price Performance
Historical ComparisonAbout GXAI Gaxos.ai Inc.
Gaxos.AI Inc is a technology company focused on reshaping the way people interact with artificial intelligence across everyday life and high-impact industries. It is engaged in building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. The company's portfolio spans defense, health and wellness, entertainment, and productivity - bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes. It operates as a single operating segment technology-based company that is developing applications aimed at redefining the way it utilizes artificial intelligence (AI) to optimize the user experience.
About PMI Picard Medical Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.